December 2nd 2023
Our November 2023 month in review for cardiology features highlights from AHA 2023, new atrial fibrillation guidelines, a pair of historic approvals from the FDA, and more!
November 28th 2023
November 28th 2023
November 26th 2023
November 26th 2023
The Ophthalmology Times EyeCon 2023
Register Now!
2023 IASLC North America Conference on Lung Cancer Satellite Symposia
Register Now!
The Optometry Times EyeCon 2023
Register Now!
PER's Breast Cancer Symposia in San Antonio
Register Now!
Leukemia Therapy – A Look Into the Future
View More
2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition
Register Now!
Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers
View More
Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care
View More
Switching Patients From 2mg to 8mg Aflibercept for nAMD and DME Treatment
December 1st 2023Retina specialists comment on switching patients from 2 mg to 8 mg of aflibercept for the management of neovascular age-related macular degeneration and diabetic macular edema and transitioning a patient who has good control with aflibercept to a newer therapy.